These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 21810389)
1. Effectiveness of bosentan in the treatment of ischemic lesions in a case of thromboangiitis obliterans (Buerger disease): a case report. Palomo-Arellano A; Cervigón-González I; Torres-Iglesias LM Dermatol Online J; 2011 Jul; 17(7):4. PubMed ID: 21810389 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of bosentan in digital ischemic ulcers. Todoli Parra JA; Hernández MM; Arrébola López MA Ann Vasc Surg; 2010 Jul; 24(5):690.e1-4. PubMed ID: 20579585 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature. Narváez J; García-Gómez C; Álvarez L; Santo P; Aparicio M; Pascual M; López de Recalde M; Borrell H; Nolla JM Medicine (Baltimore); 2016 Nov; 95(48):e5511. PubMed ID: 27902617 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of bosentan in the treatment of digital ulcers secondary to thromboangiitis obliterans]. Prior Á; Rodriguez-Muguruza S; Sanint J; Olivé A Med Clin (Barc); 2015 Jul; 145(1):44. PubMed ID: 25433787 [No Abstract] [Full Text] [Related]
6. An open-label study on long-term outcomes of bosentan for treating ulcers in thromboangiitis obliterans (Buerger's disease). De Haro J; Bleda S; Acin F Int J Cardiol; 2014 Dec; 177(2):529-31. PubMed ID: 25217217 [No Abstract] [Full Text] [Related]
7. [Thromboangiitis obliterans (Buerger disease) discovered by symptoms of arthralgia in a young woman]. Kovacsovics-Bankowski M; Gerster JC Praxis (Bern 1994); 1997 Dec; 86(49):1945-8. PubMed ID: 9480517 [TBL] [Abstract][Full Text] [Related]
10. [A role of endothelin 1 in the pathogenesis of thromboangiitis obliterans (initital news)]. Czarnacki M; Gacka M; Adamiec R Przegl Lek; 2004; 61(12):1346-50. PubMed ID: 15850327 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case report. De Haro J; Florez A; Fernandez JL; Acin F BMJ Case Rep; 2009; 2009():. PubMed ID: 21686681 [TBL] [Abstract][Full Text] [Related]
12. Inpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans (Buerger's disease). Hooten WM; Bruns HK; Hays JT Mayo Clin Proc; 1998 Jun; 73(6):529-32. PubMed ID: 9621859 [TBL] [Abstract][Full Text] [Related]
13. Spinal cord stimulation for the treatment of Buerger disease: a report on 3 cases. Fabregat G; Villanueva VL; Asensio JM; De Andrés J; López D Clin J Pain; 2011; 27(9):819-23. PubMed ID: 21593666 [TBL] [Abstract][Full Text] [Related]
14. Treatment of multiple refractory ankle ulcerations in thromboangiitis obliterans: A case report. Huang ZH; Kuo SY; Chiu YH; Chen HC; Lu CC Medicine (Baltimore); 2018 May; 97(20):e10798. PubMed ID: 29768374 [TBL] [Abstract][Full Text] [Related]
15. Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan. De Haro J; Acin F; Bleda S; Varela C; Esparza L BMC Cardiovasc Disord; 2012 Feb; 12():5. PubMed ID: 22333218 [TBL] [Abstract][Full Text] [Related]
16. Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers. Catarsi E; Doveri M; Tavoni A Reumatismo; 2013 May; 65(2):79-81. PubMed ID: 23877412 [TBL] [Abstract][Full Text] [Related]
17. Intestinal ischemia as a single manifestation of thromboangiitis obliterans--a case report. Magalhães Ede P; Trevisan M; Mochizuki M; Sachetto Z; Samara AM; Fernandes SR Angiology; 2005; 56(6):789-92. PubMed ID: 16327959 [TBL] [Abstract][Full Text] [Related]
18. Effect of eNOS and ET-1 polymorphisms in thromboangiitis obliterans. Adigüzel Y; Yilmaz E; Akar N Clin Appl Thromb Hemost; 2010 Feb; 16(1):103-6. PubMed ID: 19520685 [TBL] [Abstract][Full Text] [Related]